Effect of Coffee Consumption on the Glycemic Index of Khalas Dates Tested in Healthy and Diabetic Subjects

NCT01422668 | Completed Phase 3 DMC

• 1 other identifier: UAEU: GI Dates Study
• Study Type: interventional
• Target: 23
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study was to evaluate the composition of Khalas, a very common type of dates used in the UAE and to determine the effects of drinking Arabic coffee on the results of GI tests in both healthy and diabetic subjects.

Conditions

Diabetes Mellitus

Keywords

Glycemic index; Dates; Diabetes; Coffee

Outcome Measures

Primary Outcomes (1)

• Glycemic Index of Khalas dates with and without coffee

  Every subject recieved 50 grams reducing sugars of Khalas dates with and without coffee. Measuring glucose level over 2 hours in Healthy subjects and over 3 hours in diabetic subjects as per a standard protocol.

  2 or 3 hours

Study Arms (2)

GI of Khalas dates

ACTIVE COMPARATOR

The Glycemic indices of the Khalas dates were measured for healthy and diabetic subjects.

Other: Khalas dates

GI of the Khalas dates with Coffee

EXPERIMENTAL

measuring the effect of 100 ml of coffee consumption on the GI of the Khalas dates among healthy and diabetic subjects.

Other: Khalas dates

Interventions

Khalas dates OTHER

every subject recieved 50 grams reducing carbohydrates equivalent of khalas dates

GI of Khalas dates; GI of the Khalas dates with Coffee

Eligibility Criteria

• Age: 18 Years - 60 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• required that those in the healthy group were healthy and in the diabetes group that their diabetes was controlled (HbA1c ≤8%) on diet with or without metformin

You may not qualify if:

• morbid obesity (BMI \> 40 kg/m2)
• pre diabetes
• pregnancy
• presence of gastroenterological disorders
• alimentary tract surgery
• a history of gastroenteritis in the prior six months
• any alcohol intake
• smoking
• taking any medications (except metformin)
• poorly controlled diabetes (HbA1c \> 8%) and the presence of acute or chronic diseases

Sponsors & Collaborators

• United Arab Emirates University: lead

Study Sites (1)

Faculty of Medicine and Health Sciences UAE University

Al Ain City, AB, United Arab Emirates

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases

Study Officials

• Juma M Alkaabi, MD

  Assistant professor Internal Medicine Department FMHS UAE University

  PRINCIPAL INVESTIGATOR

• Bayan Al-Dabbag, PhD

  FMHS UAE university

  STUDY CHAIR

• Hussein Saadi, MD

  Professor of Medicine, FMHS UAE University

  STUDY CHAIR

• Salah Gariballa, MD

  Professor of Medicine FMHS UAE University

  STUDY CHAIR

• Yasin Javed, Msc

  FMHS UAE University

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: phase 3
• Allocation: NON RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor of Medicine, Faculty of Medicine and Health Sciences

Study Record Dates

• First Submitted: August 18, 2011
• First Posted: August 24, 2011
• Study Start: March 1, 2010
• Primary Completion: June 1, 2010
• Study Completion: June 1, 2010
• Last Updated: August 24, 2011

Record last verified: 2011-08

Locations

AE (1)